Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Researchers make case against Gilead in HIV product hopping fight
3 months ago
Law
Viking Therapeutics taps CordenPharma to manufacture its obesity drugs
3 months ago
Manufacturing
Legend to double Carvykti production as it targets blockbuster status
3 months ago
Cell/Gene Tx
Manufacturing
Merck scores a win in Gardasil cases after judge says plaintiffs’ evidence ‘falls far short’
3 months ago
Law
Corrected: Merck opens billion-dollar US facility to make Gardasil
3 months ago
Manufacturing
Bristol Myers buys out cell therapy partner 2seventy bio
3 months ago
Deals
Cell/Gene Tx
BioNTech's shares dip after posting lukewarm revenue guidance
3 months ago
Compounders’ motion for preliminary injunction denied in case over tirzepatide shortage
3 months ago
Law
Health Tech
Emergent sells once-troubled manufacturing site to Indian CDMO
3 months ago
Manufacturing
#AAD25: What you need to know from Amgen, Bristol Myers, J&J and more
3 months ago
R&D
Sun Pharma to acquire Checkpoint Therapeutics and its anti-PD-L1 antibody
3 months ago
Deals
Mineralys’ Phase 3 blood pressure pill data support potential FDA approval
3 months ago
R&D
Start of 2025 comes with generic drug price decreases, several major increases, report finds
3 months ago
FDA approves Neurotech cell therapy to slow a rare degenerative eye disease
3 months ago
FDA+
Bayer eyes capital raise as it grapples with Monsanto cases
3 months ago
Law
At $300M Kardigan startup, former MyoKardia team unveils its first drug, and it comes from Ionis
3 months ago
Startups
Deals
J&J axes Phase 3 depression program due to ‘insufficient efficacy’ shortly after Neumora’s study fail
3 months ago
R&D
Moderna stands by its Covid vaccine IP after decision axing two patents
3 months ago
Coronavirus
Law
Merck KGaA says earlier moves to localize manufacturing help ease Trump tariff impact
3 months ago
China
Manufacturing
Live updates: Makary likely a lock for next FDA chief after breezy Senate hearing
3 months ago
People
FDA+
No news is good news? Merck KGaA quiet on potential SpringWorks takeover
3 months ago
Deals
Judge grants new nationwide block on NIH payment cuts
3 months ago
FDA+
Law
Bavarian Nordic CEO says it can take years to move pharma manufacturing to the US
3 months ago
Manufacturing
Novo Nordisk slashes Wegovy price by nearly two-thirds for cash-paying patients
3 months ago
Marketing
First page
Previous page
13
14
15
16
17
18
19
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit